TY - JOUR A1 - Drzymala, Sarah A1 - Binder, J. A1 - Brodehl, Antje A1 - Penkert, M. A1 - Rosowski, M. A1 - Garbe, L.-A. A1 - Koch, Matthias T1 - Estrogenicity of novel phase I and phase II metabolites of zearalenone and cis-zearalenone N2 - Zearalenone and its cis-isomer, cis-zearalenone, are nonsteroidal mycotoxins that elicit an estrogenic response upon binding to the estrogen receptor. This study compares the estrogenicity of eleven congeners including novel metabolites as 15-OH-zearalenone, zearalenone-14-sulfate, α-cis-zearalenol and β-cis-zearalenol using the E-Screen assay. Overall, a change in the configuration from trans to cis retains significant estrogenic activity. In contrast, alterations of the aromatic moiety including hydroxylation and sulfation showed a markedly decreased estrogenicity when compared to zearalenone. KW - Zearalenone KW - Mycotoxin KW - MCF-7 KW - E-screen assay KW - Estrogenicity KW - Isomerization PY - 2015 U6 - https://doi.org/10.1016/j.toxicon.2015.08.027 SN - 0041-0101 SN - 1879-3150 VL - 105 SP - 10 EP - 12 PB - Elsevier CY - Oxford [u.a.] AN - OPUS4-34167 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER -